EICHORCondition: Obesity & Overweight · Sponsor: ERX Pharmaceuticals
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objective is to assess the safety and tolerability of oral dose ERX1000 in obese subjects.
This description comes directly from the study's public registry record.
Director of Patient Recruitment and Marketing · 908-952-6877 · recruitment@monroeresearch.com
Always discuss trial participation with your own doctor first.
| Monroe Biomedical Research | Louisville, Kentucky, United States | Recruiting |
| Monroe Biomedical Research | Monroe, North Carolina, United States | Recruiting |
| Monroe Biomedical Research | North Charleston, South Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07570758